Elisabeth Hannah Adam1, Dania Fischer2. 1. Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt, Germany. 2. Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
Abstract
BACKGROUND: Plasma transfusions are most commonly used therapeutically for bleeding or prophylactically in non-bleeding patients prior to invasive procedures or surgery. Although plasma transfusions generally seem to decline, plasma usage for indications that lack evidence of efficacy prevail. SUMMARY: There is wide international, interinstitutional, and interindividual variance regarding the compliance with guidelines based on published references, supported by appropriate testing. There is furthermore a profound lack of evidence from randomized controlled trials comparing the effect of plasma transfusion with that of other therapeutic interventions for most indications, including massive bleeding. The expected benefit of a plasma transfusion needs to be balanced carefully against the associated risk of adverse events. In light of the heterogeneous nature of bleeding conditions and their rapid evolvement over time, fibrinogen and factor concentrate therapy, directed at specific phases of coagulation identified by alternative laboratory assays, may offer advantages over conventional blood product ratio-driven resuscitation. However, their outcome benefit has not been demonstrated in well-powered prospective trials. This systematic review will detail the current evidence base for plasma transfusion in adult surgical patients.
BACKGROUND: Plasma transfusions are most commonly used therapeutically for bleeding or prophylactically in non-bleeding patients prior to invasive procedures or surgery. Although plasma transfusions generally seem to decline, plasma usage for indications that lack evidence of efficacy prevail. SUMMARY: There is wide international, interinstitutional, and interindividual variance regarding the compliance with guidelines based on published references, supported by appropriate testing. There is furthermore a profound lack of evidence from randomized controlled trials comparing the effect of plasma transfusion with that of other therapeutic interventions for most indications, including massive bleeding. The expected benefit of a plasma transfusion needs to be balanced carefully against the associated risk of adverse events. In light of the heterogeneous nature of bleeding conditions and their rapid evolvement over time, fibrinogen and factor concentrate therapy, directed at specific phases of coagulation identified by alternative laboratory assays, may offer advantages over conventional blood product ratio-driven resuscitation. However, their outcome benefit has not been demonstrated in well-powered prospective trials. This systematic review will detail the current evidence base for plasma transfusion in adult surgical patients.
Authors: Mohammad Hassan Murad; James R Stubbs; Manish J Gandhi; Amy T Wang; Anu Paul; Patricia J Erwin; Victor M Montori; John D Roback Journal: Transfusion Date: 2010-03-19 Impact factor: 3.157
Authors: Zoe K McQuilten; Gemma Crighton; Susan Brunskill; Jessica K Morison; Tania H Richter; Neil Waters; Michael F Murphy; Erica M Wood Journal: Transfus Med Rev Date: 2017-07-06
Authors: Sibylle A Kozek-Langenecker; Aamer B Ahmed; Arash Afshari; Pierre Albaladejo; Cesar Aldecoa; Guidrius Barauskas; Edoardo De Robertis; David Faraoni; Daniela C Filipescu; Dietmar Fries; Thorsten Haas; Matthias Jacob; Marcus D Lancé; Juan V L Pitarch; Susan Mallett; Jens Meier; Zsolt L Molnar; Niels Rahe-Meyer; Charles M Samama; Jakob Stensballe; Philippe J F Van der Linden; Anne J Wikkelsø; Patrick Wouters; Piet Wyffels; Kai Zacharowski Journal: Eur J Anaesthesiol Date: 2017-06 Impact factor: 4.330
Authors: Babak Sarani; W Jonathan Dunkman; Laura Dean; Seema Sonnad; Jeffrey I Rohrbach; Vicente H Gracias Journal: Crit Care Med Date: 2008-04 Impact factor: 7.598
Authors: Maximilian Dietrich; Tobias Hölle; Lazar Detelinov Lalev; Martin Loos; Felix Carl Fabian Schmitt; Mascha Onida Fiedler; Thilo Hackert; Daniel Christoph Richter; Markus Alexander Weigand; Dania Fischer Journal: J Clin Med Date: 2022-07-27 Impact factor: 4.964